BackNureca Limited Overview

Nureca Limited EBIT

Track Nureca Limited's EBIT ($88M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$43.94M
↓ 13.06% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

$87.57M
↑ 42.92% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Nureca Limited (NURECA.NS) FAQ

The latest EBIT for NURECA.NS is $88M as of September 2026. That compares with $61M in the prior-year period — up 42.9% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Nureca Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, NURECA.NS's EBIT moved from $61M to $88M — a 42.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nureca Limited's operating scale or balance-sheet position.

Against its sector companies, NURECA.NS currently prints $88M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Nureca Limited's growth, margins, and balance sheet.

A EBIT figure of $88M for NURECA.NS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting NURECA.NS's EBIT ($88M), review year-over-year change from $61M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.